Tagged with CanSino

China Pharma News: CanSino Gates Foundation Grant; Merck/Jiangsu Hengrui Deal
China Pharma News: AstraZeneca/CanSino mRNA Deal; Tigermed Hong Kong HQ; Biotech-Friendly Tax Breaks
Four Things to Know about CanSino Biologics
China Pharma News: Paxlovid’s Exclusion from National Insurance; CanSino’s mRNA Booster Trial; WuXi/GSK T-cell Deal; Biocytogen/Hansoh Antibody Collab
China Pharma News: CanSino’s Inhaled COVID-19 Vaccine Approval; HitGen/Unison’s Anti-Infectives Deal; Neukio Biotherapeutics Funding
Fill, Finish & Beyond: The Chinese Vaccine Developers Exporting their Ambitions Overseas
Brazil Vaccine News: Pfizer to Vaccinate Entire City; Biomm/CanSino Import Deal; Butantan’s Plans to Export Sinovac Vaccine
China Pharma News: Antitrust Threat to Pharma; June BioNTech Vaccine Approval; EpimAb IPO; CanSino Inhaled Vaccine Trials
China: AstraZeneca/Junshi anti-PD-1 Tie-Up; New UK Biologics Plan for Pharmaron; Clover’s $230 Million Investment Boost
Mexico: US Vaccine Tourism; CanSino Stepping Up; AMLO Calls for UN Intervention
China Pharma News Roundup September 2020
Hong Kong Biotech IPOs since Listing Reform in April 2018
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here